Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study) (DECIDE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00911703 |
Recruitment Status
:
Completed
First Posted
: June 2, 2009
Last Update Posted
: April 29, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Acute Heart Failure |
Study Type : | Observational |
Actual Enrollment : | 835 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Treatment Endpoints in Acute Decompensated Heart Failure |
Study Start Date : | August 2008 |
Actual Primary Completion Date : | July 2014 |
Actual Study Completion Date : | October 2015 |

Group/Cohort |
---|
Acute heart failure
Subjects with an ED diagnosis of acute decompensated heart failure .
|
- Heart-failure related adverse events [ Time Frame: Measured 5 days and 30 days after ED presentation ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Fulfill the modified Framingham criteria
- Have baseline data available within 1 hour of initial ED therapy
- Have previously documented systolic dysfunction (ejection fraction less than 50%) by echocardiogram
- Willing and able to give informed consent
The exclusion criteria are:
- Patients less than 18 years of age.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00911703
United States, Ohio | |
University of Cincinnati | |
Cincinnati, Ohio, United States, 45267 | |
United States, Tennessee | |
Vanderbilt University | |
Nashville, Tennessee, United States, 37232 |
Principal Investigator: | Sean P. Collins, MD, MSc | Vanderbilt University Emergency Medicine |
Responsible Party: | Sean Collins, Associate Proffesor of Emergency Medicine, Vanderbilt University |
ClinicalTrials.gov Identifier: | NCT00911703 History of Changes |
Other Study ID Numbers: |
659 K23HL085387-06 ( U.S. NIH Grant/Contract ) K23HL085387-01A2 ( U.S. NIH Grant/Contract ) |
First Posted: | June 2, 2009 Key Record Dates |
Last Update Posted: | April 29, 2016 |
Last Verified: | December 2014 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Additional relevant MeSH terms:
Heart Failure Heart Diseases Cardiovascular Diseases |